Tumor-associated neutrophils: Friend or foe?

Carcinogenesis

Volumn 33, Issue 5, 2012, Pages 949-955

  Fridlender, Zvi G ^a,b   Albelda, Steven M ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ARGINASE; CHEMOKINE RECEPTOR CXCR2; COLLAGENASE; CXCL2 CHEMOKINE; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUTROPHIL COLLAGENASE; VASCULOTROPIN;

ADVANCED CANCER; ANGIOGENESIS; APOPTOSIS; CANCER SURVIVAL; CARCINOGENESIS; CLEAR CELL CARCINOMA; CYTOKINE RELEASE; CYTOSKELETON; CYTOTOXICITY; DENDRITIC CELL; EXTRAVASATION; GLIOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; IMMUNE SYSTEM; KIDNEY CARCINOMA; MELANOMA; METASTASIS; NEOPLASM; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHILIA; OVERALL SURVIVAL; PANCREAS TUMOR; PHAGOCYTOSIS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; RESPIRATORY BURST; REVIEW; TUMOR ASSOCIATED NEUTROPHIL; TUMOR GROWTH; TUMOR REJECTION;

EID: 84860484044     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs123     Document Type: Review

References (113)

1. Welch, D.R. et al. (1989) Tumor-elicited polymorphonuclear cells, in contrast to "normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc. Natl Acad. Sci USA, 86, 5859-5863.
2. Piccard, H. et al. (2011) On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit. Rev. Oncol. Hematol. doi:10.1016/j.critrevonc.2011.06.004. [Epub ahead of print].
3. Mantovani, A. et al. (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol., 11, 519-531.
4. Heifets, L. (1982) Centennial of Metchnikoff's discovery. J. Reticuloendothel. Soc., 31, 381-391.
5. Shojaei, F. et al. (2008) Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc. Natl Acad. Sci. USA, 105, 2640-2645.
6. Fridlender, Z.G. et al. (2009) Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell, 16, 183-194.
7. Gregory, A.D. et al. (2011) Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res., 71, 2411-2416.
8. Peranzoni, E. et al. (2010) Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol., 22, 238-244.
9. Ashtekar, A. et al. (2003) Poly's plea: membership to the club of APC's. Trends Immunol., 24, 485-490.
10. Nagaraj, S. et al. (2010) Mechanism of T cell tolerance induced by myeloid-derived suppressor cells. J. Immunol., 184, 3106-3116.
11. Youn, J.I. et al. (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol., 181, 5791-5802.
12. Movahedi, K. et al. (2008) Identification of discrete tumor-induced myeloidderived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood, 111, 4233-4244.
13. Gabrilovich, D.I. et al. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol., 9, 162-174.
14. Mantovani, A. et al. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol., 23, 549-555.
15. Yunping, L. et al. (2006) Targeting tumor-associated macrophages as a novel strategy against breast cancer. J. Clin. Invest., 116, 2132-2141.
16. Schmidt, H. et al. (2005) Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br. J. Cancer, 93, 273-278.
17. McGary, C.T. et al. (1995) Highly metastatic 13762NF rat mammary adenocarcinoma cell clones stimulate bone marrow by secretion of granulocytemacrophage colony-stimulating factor/interleukin-3 activity. Am. J. Pathol., 147, 1668-1681.
18. Lechner, M.G. et al. (2010) Characterization of cytokine-induced myeloidderived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol., 185, 2273-2284.
19. Bellocq, A. et al. (1998) Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am. J. Pathol., 152, 83-92.
20. Atzpodien, J. et al. (2008) Peripheral blood neutrophils as independent immunologic predictor of response and long-term survival upon immunotherapy in metastatic renal-cell carcinoma. Cancer Biother. Radiopharm., 23, 129-134.
21. Walsh, S.R. et al. (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J. Surg. Oncol., 91, 181-184.
22. Sarraf, K.M. et al. (2009) Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J. Thorac. Cardiovasc. Surg., 137, 425-428.
23. Donskov, F. et al. (2006) Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. J. Clin. Oncol., 24, 1997-2005.
24. Jensen, H.K. et al. (2009) Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J. Clin. Oncol., 27, 4709-4717.
25. Trellakis, S. et al. (2011) Peripheral blood neutrophil granulocytes from patients with head and neck squamous cell carcinoma functionally differ from their counterparts in healthy donors. Int. J. Immunopathol. Pharmacol., 24, 683-693.
26. Fossati, G. et al. (1999) Neutrophil infiltration into human gliomas. Acta Neuropathol., 98, 349-354.
27. Reid, M.D. et al. (2011) Tumor-infiltrating neutrophils in pancreatic neoplasia. Mod. Pathol., 24, 1612-1619.
28. Caruso, R.A. et al. (2002) Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod. Pathol., 15, 831-837.
29. Dumitru, C.A. et al. (2011) Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int. J. Cancer, 129, 859-869.
30. De Larco, J.E. et al. (2004) The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin. Cancer Res., 10, 4895-4900.
31. De Larco, J.E. et al. (2003) Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells. Proc. Natl Acad. Sci. USA, 100, 13988-13993.
32. Sparmann, A. et al. (2004) Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell, 6, 447-458.
33. Wang, L.C. et al. (2009) Neutrophil influx and chemokine production during the early phases of the antitumor response to the vascular disrupting agent DMXAA (ASA404). Neoplasia, 11, 793-803.
34. Kobayashi, Y. (2008) The role of chemokines in neutrophil biology. Front. Biosci., 13, 2400-2407.
35. Wengner, A.M. et al. (2008) The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation. Blood, 111, 42-49.
36. Eash, K.J. et al. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J. Clin. Invest., 120, 2423-2431.
37. Khajah, M. et al. (2011) Granulocyte-macrophage colony-stimulating factor (GM-CSF): a chemoattractive agent for murine leukocytes in vivo. J. Leukoc. Biol., 89, 945-953.
38. Gomez-Cambronero, J. et al. (2003) Granulocyte-macrophage colonystimulating factor is a chemoattractant cytokine for human neutrophils: involvement of the ribosomal p70 S6 kinase signaling pathway. J. Immunol., 171, 6846-6855.
39. Ueha, S. et al. (2011) Myeloid cell population dynamics in healthy and tumor-bearing mice. Int. Immunopharmacol., 11, 783-788.
40. Eash, K.J. et al. (2010) CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J. Clin. Invest., 120, 2423-2431.
41. Fridlender, Z.G. et al. (2012) Transcriptomic analysis comparing tumorassociated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils. PLoS One, 7, e31524.
42. Appelberg, R. (1992) Mycobacterial infection primes T cells and macrophages for enhanced recruitment of neutrophils. J. Leukoc. Biol., 51, 472-477.
43. Kobayashi, Y. (2006) Neutrophil infiltration and chemokines. Crit. Rev. Immunol., 26, 307-315.
44. Verbeke, H. et al. (2011) Isotypic neutralizing antibodies against mouse GCP-2/CXCL6 inhibit melanoma growth and metastasis. Cancer Lett., 302, 54-62.
45. Kim, S. et al. (2008) Systemic blockade of transforming growth factorbeta signaling augments the efficacy of immunogene therapy. Cancer Res., 68, 10247-10256.
46. Maus, U.A. et al. (2003) Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis. J. Immunol., 170, 3273-3278.
47. Smith, W.B. et al. (1996) Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. J. Immunol., 157, 360-368.
48. Allen, S.S. et al. (2008) Altered inflammatory responses following transforming growth factor-[beta] neutralization in experimental guinea pig tuberculous pleurisy. Tuberculosis, 88, 430-436.
49. Stoppacciaro, A. et al. (1993) Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma. J. Exp. Med., 178, 151-161.
50. Aruga, A. et al. (1997) Different cytokine profiles released by CD4+ and CD8+ tumor-draining lymph node cells involved in mediating tumor regression. J. Leukoc. Biol., 61, 507-516.
51. Sherwood, E.R. et al. (2004) Mice depleted of CD8+ T and NK cells are resistant to injury caused by cecal ligation and puncture. Lab. Invest., 84, 1655-1665.
52. Iking-Konert, C. et al. (2008) T lymphocytes in patients with primary vasculitis: expansion of CD8+ T cells with the propensity to activate polymorphonuclear neutrophils. Rheumatology, 47, 609-616.
53. Richards, H. et al. (2010) Novel role of regulatory T cells in limiting early neutrophil responses in skin. Immunology, 131, 583-592.
54. Himmel, M.E. et al. (2011) Human CD4+ FOXP3+ regulatory T cells produce CXCL8 and recruit neutrophils. Eur. J. Immunol., 41, 306-312.
55. Reiman, J.M. et al. (2007) Tumor immunoediting and immunosculpting pathways to cancer progression. Semin. Cancer Biol., 17, 275-287.
56. Queen, M.M. et al. (2005) Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res., 65, 8896-8904.
57. Morales, J. et al. (2010) GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells. Breast Cancer Res. Treat., 123, 39-49.
58. Dolcetti, L. et al. (2010) Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol., 40, 22-35.
59. Kusmartsev, S. et al. (2005) Tumor-associated CD8+ T Cell tolerance induced by bone marrow-derived immature myeloid cells. J. Immunol., 175, 4583-4592.
60. Shen, L. et al. (2007) Inhibition of human neutrophil degranulation by transforming growth factor-beta. Clin. Exp. Immunol., 149, 155-161.
61. Theilgaard-Monch, K. et al. (2005) The transcriptional program of terminal granulocytic differentiation. Blood, 105, 1785-1796.
62. Sawanobori, Y. et al. (2008) Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood, 111, 5457-5466.
63. Scapini, P. et al. (2000) The neutrophil as a cellular source of chemokines. Immunol. Rev., 177, 195-203.
64. Van Gisbergen, K.P. et al. (2005) Close encounters of neutrophils and DCs. Trends Immunol., 26, 626-631.
65. Abi Abdallah, D.S. et al. (2011) Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation. Int. Immunol., 23, 317-326.
66. Curiel, T.J. et al. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med., 10, 942-949.
67. Pekarek, L.A. et al. (1995) Inhibition of tumor growth by elimination of granulocytes. J. Exp. Med., 181, 435-440.
68. Tazawa, H. et al. (2003) Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am. J. Pathol., 163, 2221-2232.
69. Schmielau, J. et al. (2001) Activated granulocytes and granulocytederived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res., 61, 4756-4760.
70. Nozawa, H. et al. (2006) Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl Acad. Sci. USA, 103, 12493-12498.
71. Coussens, L.M. et al. (2002) Inflammation and cancer. Nature, 420, 860-867.
72. Acuff, H.B. et al. (2006) Matrix metalloproteinase-9 from bone marrowderived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res., 66, 259-266.
73. Loukinova, E. et al. (2000) Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene, 19, 3477-3486.
74. Hirose, K. et al. (1995) Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration. Br. J. Cancer, 72, 708-714.
75. Houghton, A.M. et al. (2010) Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat. Med., 16, 219-223.
76. Tazzyman, S. et al. (2009) Neutrophils: key mediators of tumour angiogenesis. Int. J. Exp. Pathol., 90, 222-231.
77. Jablonska, J. et al. (2010) Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J. Clin. Invest., 120, 1151-1164.
78. Kuang, D.M. et al. (2011) Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J. Hepatol., 54, 948-955.
79. Shojaei, F. et al. (2007) Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. Nat. Biotech., 25, 911-920.
80. Masson, V. et al. (2005) Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J., 19, 234-236.
81. Gijsbers, K. et al. (2005) GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors. Exp. Cell Res., 303, 331-342.
82. Schaider, H. et al. (2003) Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int. J. Cancer, 103, 335-343.
83. Wu, Q.D. et al. (2001) Human neutrophils facilitate tumor cell transendothelial migration. Am. J. Physiol. Cell Physiol., 280, C814-C822.
84. Orr, F.W. et al. (2001) Tumor cell interactions with the microvasculature: a rate-limiting step in metastasis. Surg. Oncol. Clin. N. Am., 10, 357-381, ix-x.
85. Sato, T. et al. (2006) Neutrophil elastase and cancer. Surg. Oncol., 15, 217-222.
86. Sun, Z. et al. (2004) Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. Lancet Oncol., 5, 182-190.
87. Doi, K. et al. (2002) Neutrophil elastase inhibitor reduces hepatic metastases induced by ischaemia-reperfusion in rats. Eur. J. Surg., 168, 507-510.
88. Huh, S.J. et al. (2010) Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Res., 70, 6071-6082.
89. Tvinnereim, A.R. et al. (2004) Neutrophil involvement in crosspriming CD8+ T Cell responses to bacterial antigens. J. Immunol., 173, 1994-2002.
90. Di Carlo, E. et al. (2001) The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood, 97, 339-345.
91. Kousis, P.C. et al. (2007) Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils. Cancer Res., 67, 10501-10510.
92. Colombo, M.P. et al. (1992) Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res., 52, 4853-4857.
93. Rodriguez, P.C. et al. (2004) Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res., 64, 5839-5849.
94. Rotondo, R. et al. (2009) IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer. Int. J. Cancer, 125, 887-893.
95. Colombo, M.P. et al. (1992) Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophilmediated tumor inhibition in vivo. Neutrophils discriminate between G-CSF-producing and G-CSF-nonproducing tumor cells. J. Immunol., 149, 113-119.
96. Hicks, A.M. et al. (2006) Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc. Natl Acad. Sci. USA, 103, 7753-7758.
97. Suttmann, H. et al. (2006) Neutrophil granulocytes are required for effective Bacillus Calmette-Guerin immunotherapy of bladder cancer and orchestrate local immune responses. Cancer Res., 66, 8250-8257.
98. Balbin, M. et al. (2003) Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat. Genet., 35, 252-257.
99. Gerrard, T.L. et al. (1981) Human neutrophil-mediated cytotoxicity to tumor cells. J. Natl Cancer Inst., 66, 483-488.
100. Katano, M. et al. (1982) Neutrophil-mediated tumor cell destruction in cancer ascites. Cancer, 50, 62-68.
101. Ishihara, Y. et al. (1998) The role of neutrophils as cytotoxic cells in lung metastasis: suppression of tumor cell metastasis by a biological response modifier (PSK). In Vivo, 12, 175-182.
102. Ishihara, Y. et al. (1998) Contribution of cytokines on the suppression of lung metastasis. Biotherapy, 11, 267-275.
103. Lichtenstein, A. et al. (1989) Human neutrophil-mediated lysis of ovarian cancer cells. Blood, 74, 805-809.
104. Zivkovic, M. et al. (2007) Oxidative burst of neutrophils against melanoma B16-F10. Cancer Lett., 246, 100-108.
105. Granot, Z. et al. (2011) Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell, 20, 300-314.
106. Chen, Y.L. et al. (2003) Fas ligand on tumor cells mediates inactivation of neutrophils. J. Immunol., 171, 1183-1191.
107. Hubert, P. et al. (2011) Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy. Cancer Res., 71, 5134-5143.
108. Schneider-Merck, T. et al. (2010) Human IgG2 antibodies against epidermal growth factor receptor effectively trigger antibody-dependent cellular cytotoxicity but, in contrast to IgG1, only by cells of myeloid lineage. J. Immunol., 184, 512-520.
109. Di Carlo, E. et al. (2001) Neutrophils in anti-cancer immunological strategies: old players in new games. J. Hematoth. Stem Cell, 10, 739-748.
110. Beauvillain, C. et al. (2007) Neutrophils efficiently cross-prime naive T cells in vivo. Blood, 110, 2965-2973.
111. Cavallo, F. et al. (1992) Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J. Immunol., 149, 3627-3635.
112. Medina-Echeverz, J. et al. (2011) Successful colon cancer eradication after chemoimmunotherapy is associated with profound phenotypic change of intratumoral myeloid cells. J. Immunol., 186, 807-815.
113. Breitbach, C.J. et al. (2007) Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow. Mol. Ther., 15, 1686-1693.